Desai R, Bruce J
Department of Neurosurgery, College of Physicians and Surgeons of Columbia University, New York, New York.
J Neurooncol. 1994;20(3):255-79. doi: 10.1007/BF01053043.
Treatment objectives for meningiomas of the cranial base include relief of neurologic disability and prevention of clinical progression or recurrence with the least morbidity. Recent advances in skull base surgical techniques, through an appreciation of skull base anatomy and institutional specialization, have contributed major improvements to the outlook for patients with these tumors, and previously inoperable cases may now often be removed completely with acceptable risk. Since significant morbidity may be incurred during surgical resection of these difficult lesions, especially in terms of cranial nerve dysfunction, the value of aggressive surgical resection must be weighted against the often indolent natural history of these lesions, and must be individualized in each patient. Completeness of resection is the major prognostic factor determining the outcome of patients with typical benign meningiomas in terms of length of survival, risk of recurrence, and neurological disability. Various means of prognosticating the growth potential of a given tumor are being investigated, though none have yet been confirmed for their predictive value in typical, histologically benign meningiomas. The role of external beam radiotherapy has not been subjected to adequately controlled, prospective studies, and there is currently insufficient followup to assess the risks and benefits of stereotactic radiosurgery. Advances in the clinical management of tumors of the skull base has had perhaps the greatest impact for patients with meningiomas who constitute a large portion of tumors seen in these locations. Although the majority have benign histological features, skull base meningiomas can present a formidable challenge due to their proximity to vital structures, surgical inaccessibility, and occasional aggressive features. The combination in recent years of advances in skull base surgical techniques, adjuvant therapy, and rehabilitation methods have dramatically improved the outcome for these tumors.
颅底脑膜瘤的治疗目标包括缓解神经功能障碍,以及以最低的发病率预防临床进展或复发。通过对颅底解剖结构的认识和机构专业化,颅底外科技术的最新进展为这些肿瘤患者的预后带来了重大改善,以前无法手术的病例现在通常可以在可接受的风险下完全切除。由于在手术切除这些困难病变时可能会发生显著的发病率,特别是在颅神经功能障碍方面,积极手术切除的价值必须与这些病变通常进展缓慢的自然病程相权衡,并且必须针对每个患者进行个体化评估。切除的完整性是决定典型良性脑膜瘤患者生存长度、复发风险和神经功能障碍预后的主要因素。尽管尚未证实任何一种方法在典型的组织学良性脑膜瘤中的预测价值,但目前正在研究各种预测特定肿瘤生长潜力的方法。外照射放疗的作用尚未经过充分对照的前瞻性研究,目前也没有足够的随访来评估立体定向放射外科的风险和益处。颅底肿瘤临床管理的进展对脑膜瘤患者的影响可能最大,脑膜瘤在这些部位的肿瘤中占很大比例。尽管大多数脑膜瘤具有良性组织学特征,但由于其靠近重要结构、手术难以触及以及偶尔具有侵袭性特征,颅底脑膜瘤可能带来巨大挑战。近年来,颅底外科技术、辅助治疗和康复方法的进步相结合,显著改善了这些肿瘤的治疗效果。